The need for new anti-infective agents and strategies is underscored by recent acceleration in bacterial resistance to existing antibiotics and the exhaustion of currently known targets of microbial cell biology and biochemistry. Further anti-infectives development will be driven by discovery of the pathogenic molecular processes of infectious diseases, which are often initiated by host-pathogen encounters at epithelial surfaces. Urinary tract infections (UTIs), a major source of morbidity and medical costs worldwide, are caused primarily by uropathogenic Escherichia coli, which employ an adhesive fiber termed the type 1 pilus to bind and invade bladder epithelial cells. Recurrences are common after acute UTI, and recent data suggest that bacteria establish chronic residence within bladder tissue, resist oral antibiotic therapy, and re-emerge to cause these recurrences. In this application, we propose to deliver anti-infective agents into epithelial cells via the conjugation of antimicrobial-bearing polymer nanoparticles (NPs) with a bacterial adhesin, a protein that confers epithelial binding and invasion capacity upon our model Gram-negative pathogen. Our first objective will be to refine the chemical processes by which a subject protein (specifically the binding domain of the E. coli type 1 pilus adhesin FimH) can be conjugated with favorable orientation and distribution to the exterior of a series of polymer NPs. Second, we will demonstrate the adhesin-dependent internalization of these functionalized NPs into bladder epithelial cells in vitro and in vivo, providing uniquely available controls to prove the specificity of the adhesin-receptor interaction. Third, we will optimize the loading of silver cation and structurally modifiable silver carbene antimicrobials into the NPs. Finally, we propose to demonstrate the anti-infective activity of these antimicrobial-bearing, adhesin-coupled NPs, both in vitro and in murine models of acute and chronic cystitis caused by uropathogenic E. coli. Advantages of this system include the capability to deliver antimicrobials in high concentration to the intracellular compartment where pathogens may reside, avoidance of toxicities associated with systemic antibiotic and NP administration, and flexibility in the structural design of both the protein """"""""coat"""""""" and the antimicrobial passenger. Though we will model the utility of our system using bacterial infection of the mammalian urinary tract, the delivery of pharmacologic agents of choice into selected epithelial cell populations will have broader applications spanning infectious diseases, cancer, and vaccine antigen delivery.

Public Health Relevance

Recurrent urinary tract infection (UTI) plagues many otherwise healthy women and complicates other urinary tract conditions. We propose to develop nanoscopic particles bearing silver-based antibacterial agents and coated with a bacterial protein to confer adhesion to the bladder surface. We will evaluate the ability of these nanoparticles to prevent and treat UTI.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK082546-03
Application #
8321543
Study Section
Gene and Drug Delivery Systems Study Section (GDD)
Program Officer
Mullins, Christopher V
Project Start
2010-08-01
Project End
2015-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
3
Fiscal Year
2012
Total Cost
$305,348
Indirect Cost
$66,641
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Olson, Patrick D; Hruska, Keith A; Hunstad, David A (2016) Androgens Enhance Male Urinary Tract Infection Severity in a New Model. J Am Soc Nephrol 27:1625-34
Olson, Patrick D; Hunstad, David A (2016) Subversion of Host Innate Immunity by Uropathogenic Escherichia coli. Pathogens 5:
Lim, Young H; Tiemann, Kristin M; Hunstad, David A et al. (2016) Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8:842-871
Hannan, Thomas J; Hunstad, David A (2016) A Murine Model for Escherichia coli Urinary Tract Infection. Methods Mol Biol 1333:159-75
Lim, Young H; Tiemann, Kristin M; Heo, Gyu Seong et al. (2015) Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide). ACS Nano 9:1995-2008
Elsabahy, Mahmoud; Wooley, Karen L (2015) Data Mining as a Guide for the Construction of Cross-Linked Nanoparticles with Low Immunotoxicity via Control of Polymer Chemistry and Supramolecular Assembly. Acc Chem Res 48:1620-30
Elsabahy, Mahmoud; Heo, Gyu Seong; Lim, Soon-Mi et al. (2015) Polymeric Nanostructures for Imaging and Therapy. Chem Rev 115:10967-1011
Danka, Elizabeth S; Hunstad, David A (2015) Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. J Infect Dis 211:1164-73
Wagers, Patrick O; Tiemann, Kristin M; Shelton, Kerri L et al. (2015) Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model. Antimicrob Agents Chemother 59:5494-502
Wright, Brian D; Deblock, Michael C; Wagers, Patrick O et al. (2015) Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines. Med Chem Res 24:2838-2861

Showing the most recent 10 out of 25 publications